Although BCR-ABL plays a central role in the pathogenesis of CML-CP, the unrestrained expression and continuous activity of BCR-ABL kinase itself are thought to accelerate the disease [3]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.